Enhanced migration and immunoregulatory capacity of BMSCs mediated by overexpression of CXCR4 and IL-35
Authors:
Open Access
- 28 July 2022
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 150, 1-8
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81473493, 81871473)
This publication has 33 references indexed in Scilit:
- Dual expression of CXCR4 and IL-35 enhances the therapeutic effects of BMSCs on TNBS-induced colitis in rats through expansion of Tregs and suppression of Th17 cellsBiochemical and Biophysical Research Communications, 2018
- CXCR5-Overexpressing Mesenchymal Stromal Cells Exhibit Enhanced Homing and Can Decrease Contact HypersensitivityMolecular Therapy, 2017
- N-cadherin adhesive interactions modulate matrix mechanosensing and fate commitment of mesenchymal stem cellsNature Materials, 2016
- Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implicationsNature Immunology, 2014
- CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injuryAmerican Journal of Physiology-Renal Physiology, 2013
- Mesenchymal Stem Cells Overexpressing C-X-C Chemokine Receptor Type 4 Improve Early Liver Regeneration of Small-for-Size Liver GraftsLiver Transplantation, 2012
- Prevention of Autoimmune Diabetes by Ectopic Pancreatic β-Cell Expression of Interleukin-35Diabetes, 2012
- Engineered cell homingBlood, 2011
- Nitric Oxide Donor Upregulation of Stromal Cell-Derived Factor-1/Chemokine (CXC Motif) Receptor 4 Enhances Bone Marrow Stromal Cell Migration into Ischemic Brain After StrokeStem Cells, 2007
- Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following cultureLeukemia, 2003